Yu Jeong Bang

Phase III, randomised trial of avelumab versus physician’s choice of chemotherapy as third-line treatment of patients with advanced gastric or gastro-oesophageal junction cancer: primary analysis of JAVELIN Gastric 300

Yu Jeong Bang, Eduardo Yañez Ruiz, Eric Van Cutsem et al. · Annals of Oncology · 2018 · 503 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Sunitinib in pancreatic neuroendocrine tumors: updated progression-free survival and final overall survival from a phase III randomized study

Sandrine Faivre, Patricia Niccoli, Daniel Castellano et al. · Annals of Oncology · 2016 · 192 citations · Full text

Medicine, Oncology, Pharmacology +13

Phase Ib study of atezolizumab combined with cobimetinib in patients with solid tumors

Matthew D. Hellmann, T. W. Kim, Chul‐min Lee et al. · Annals of Oncology · 2019 · 190 citations · Full text

Medicine, Oncology, Pharmacology +11

A randomized, open-label study of the efficacy and safety of AZD4547 monotherapy versus paclitaxel for the treatment of advanced gastric adenocarcinoma with FGFR2 polysomy or gene amplification

Eric Van Cutsem, Yu Jeong Bang, Wasat Mansoor et al. · Annals of Oncology · 2017 · 187 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

The diagnosis and management of gastric cancer: expert discussion and recommendations from the 12th ESMO/World Congress on Gastrointestinal Cancer, Barcelona, 2010

Eric Van Cutsem, Mario Dicato, Ravit Geva et al. · Annals of Oncology · 2011 · 130 citations · Full text

Medicine, Oncology, Surgery +17